Evidence map›Paper›PMID 39950317›Full record

ArticleMolecular medicine reports2025

[Retracted] lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis.

Kun Fang, Zheng-Jie Xu, Su-Xiao Jiang, De-Sheng Tang, Chang-Sheng Yan, You-Yuan Deng, Fu-Ying Zhao

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kun FangDepartment of Surgery, Yinchuan Maternal and Child Health Hospital, Yinchuan, Ningxia 750001, P.R. China.
Zheng-Jie XuDepartment of Surgery, Yinchuan Maternal and Child Health Hospital, Yinchuan, Ningxia 750001, P.R. China.
Su-Xiao JiangDepartment of Surgery, Yinchuan Maternal and Child Health Hospital, Yinchuan, Ningxia 750001, P.R. China.
De-Sheng TangDepartment of Surgical Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Chang-Sheng YanDepartment of Surgical Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
You-Yuan DengDepartment of Surgery, Xiangtan Central Hospital, Xiangtan, Hunan 411100, P.R. China.
Fu-Ying ZhaoDepartment of Gynecology, Yinchuan Maternal and Child Health Hospital, Yinchuan, Ningxia 750001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell migration and invasion assay data shown in Fig. 2C and D on p. 4 were strikingly similar to data that had already been published in different form in other articles written by different authors from different research institutes, some of which have now been retracted. Owing to the fact that the contentious data in the above article had already been published prior to its submission to

Indexed as

breast cancerglycolysishsa‑miR‑195‑5plncRNA FGD5‑AS1SNF1‑like kinase 2

Identifiers

PMID39950317
PMCPMC11833423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.